A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response.
about
Current and emerging treatment options in the management of lupusIntravenous immunoglobulin in the therapeutic armamentarium of systemic lupus erythematosus: a systematic review and meta-analysisThe role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: A review of literatureHematological disorders in patients with systemic lupus erythematosus.ANA Negative Systemic Lupus Erythematosus Leading to CTEPH, TTP-Like Thrombocytopenia, and Skin Ulcers.Leg ulcers in antiphospholipid syndrome secondary to systemic lupus erythematosus treated with intravenous immunoglobulin.Therapy of systemic lupus erythematosus: new agents and new evidence.Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.High-dose intravenous immunoglobulins for lupus nephritis--a salvage immunomodulation.Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.Immunomodulation of autoimmune diseases by high-dose intravenous immunoglobulins.Intravenous immunoglobulin in neurological disease: a specialist review.Current and novel therapeutics in the treatment of systemic lupus erythematosusBiologic therapy for autoimmune diseases: an update.Indications for IVIG in rheumatic diseasesIVIG--mechanisms of action.IVIG in autoimmunity and cancer--efficacy versus safety.Efficacy of Intravenous Immunoglobulin Monotherapy in Patients with Cutaneous Lupus Erythematosus: Results of Proof-of-Concept StudyAnti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity.High-dose intravenous immunoglobulin therapy for eosinophilic granulomatosis with polyangiitis.Central nervous system lupus: a clinical approach to therapy.Intravenous immunoglobulins improve the function and ameliorate joint involvement in systemic sclerosis: a pilot studyClinical uses of intravenous immunoglobulin.Intravenous immunoglobulin in the management of lupus nephritis.Role of hsp90 in systemic lupus erythematosus and its clinical relevanceThe management of pediatric systemic lupus erythematosus.Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.Intravenous immunoglobulin and cytokines: focus on tumor necrosis factor family members BAFF and APRIL.The use of i.v. IG therapy in dermatology.Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus.Chemosis as a presenting symptom of systemic lupus erythematosus.Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside.The steroid-sparing effect of intravenous immunoglobulin in patients with autoimmune diseases.Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report.Balancing efficacy and toxicity of novel therapies in systemic lupus erythematosus.Reviewing the recommendations for lupus in children.Sugar-free, glycine-stabilized intravenous immunoglobulin prevents skin but not renal disease in the MRL/lpr mouse model of systemic lupus.Intravenous immunoglobulin: a biological corticosteroid-sparing agent in some autoimmune conditions.Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris.Intravenous immunoglobulin therapy leading to dramatic improvement in a patient with systemic juvenile idiopathic arthritis and severe pericarditis resistant to steroid pulse therapy.
P2860
Q26741266-F1C7CE14-23C7-4B61-9A9C-FDD664533C12Q26851698-C722EA10-EE3A-470B-963E-107E854E0075Q28067526-352E5F69-4959-4C0C-8EDE-258D38B321ABQ33411323-3C7693B4-4CA4-4C78-AB62-509BF1839B57Q33430964-162D2494-7A80-462C-BB40-569D950C73D2Q33890858-111D7467-B45C-48B7-A93B-D27537E17536Q34074960-F66A0D16-F59A-472B-BE8E-D20D8D57137BQ34170097-B68AF5FA-C107-4379-B923-B869D9A9CBB0Q34227053-492AEF78-4BA8-4590-99F4-AEB72544B4BDQ34240254-DA924BE0-DB2B-4027-83F3-7BB2E393E781Q34516575-FDFDA2E7-9A59-4046-92C5-0683FDF95209Q34574581-84C32F17-0987-453D-97FD-DFFA5506A8FAQ34648851-A66138F8-4F3D-49D1-BB6F-22D1CDDDE4A6Q34655597-EA31364E-0CC9-4476-B901-8DA14CE139F6Q35102141-F4BE9001-DBD9-4CD9-A722-EC8E6A5A3742Q35161081-F84B7918-8725-40C1-A94B-3453E2E847E9Q35194511-15D59914-5B4F-4B8A-A86E-D0FA5AF8C0EDQ35289684-F422C3B7-FBCD-4271-9D59-13B77EC2591CQ35555094-DE532EEB-DA80-4FE4-AED9-3A8F785257B7Q35563312-0647B619-9D2F-49B2-8565-A4E61CBE6C29Q35625240-68A5929D-6A69-4D56-9F06-9BD5BE4B8642Q35954432-E68E1233-6035-4BD4-9A39-79DCF6A11CA5Q36264883-F1CA7DBC-D7E6-4451-89D3-9A60B210C6DCQ36302368-FD164E6E-43A4-4539-A71A-A1986633F376Q36317684-0FEB7AF7-4489-42BC-B5ED-C9274A343AFBQ36577380-1DCD1E18-C738-4EC6-A150-27D0A85BA4B9Q36794149-81B2A643-22F3-40DD-AEFB-5711BF9D88D5Q36958361-60E8D355-79DA-492F-AE27-119F632B05DBQ36986054-BBB60076-6D4C-47FB-B736-B625FD7029A9Q37351240-E69FA3BA-AB25-4EB8-8989-99AF6A9C0B13Q37414041-8A401DC2-8DE3-4CAB-971A-DED73D2B922EQ37578120-BB0EA3A8-7272-4119-82B8-4EEDA6AA9BA0Q37754661-2333D332-9478-436A-BD1C-ED8E55C96BC9Q37954539-346FDD7C-846C-41C8-9EB3-2DF855134A5BQ37960525-1EB8D34A-1174-413D-A97D-016A0BD4B88CQ38374309-87F897ED-13D6-4FDF-8DBE-9432EF8E9D7DQ39207717-F9DDB6DB-3C9C-465E-927A-9DB728900F41Q39248920-11373011-3A89-4FE6-B5D1-8ECD3ADB3C6AQ39825419-04CC39BA-F8A4-4CBF-9988-A97449466552Q40363551-72242BE7-E164-4758-967A-34C4BC73E881
P2860
A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A study of 20 SLE patients wit ...... inical and serologic response.
@ast
A study of 20 SLE patients wit ...... inical and serologic response.
@en
A study of 20 SLE patients wit ...... inical and serologic response.
@nl
type
label
A study of 20 SLE patients wit ...... inical and serologic response.
@ast
A study of 20 SLE patients wit ...... inical and serologic response.
@en
A study of 20 SLE patients wit ...... inical and serologic response.
@nl
prefLabel
A study of 20 SLE patients wit ...... inical and serologic response.
@ast
A study of 20 SLE patients wit ...... inical and serologic response.
@en
A study of 20 SLE patients wit ...... inical and serologic response.
@nl
P2093
P2860
P50
P1433
P1476
A study of 20 SLE patients wit ...... inical and serologic response.
@en
P2093
P2860
P304
P356
10.1191/096120399678841007
P577
1999-01-01T00:00:00Z